Synopsis
Develop the ability to combine clinical assessment, appropriate imaging and image-guided tissue sampling so that agreement or discordance drives a safe breast diagnosis, while explaining uncertainty and arranging reliable review.
- Triple assessment integrates clinical examination, appropriate breast imaging and image-guided histological sampling when the abnormality requires tissue diagnosis.
- Each component must address the same lesion; three completed reports do not create concordance if their sites or explanations differ.
- Mammography and ultrasound contribute morphology and distribution, while clinical examination supplies the symptom map and pathology supplies sampled biology.
Reasoning priorities
Localise the symptomatic or screen-detected target and define associated signs.
A normal examination can coexist with mammographic abnormality, while a concerning palpable lesion can require resolution despite initially benign imaging.
Worked reasoning
Screening mammography shows architectural distortion. Ultrasound finds a subtle correlate, core biopsy returns benign fibrosis, and the distortion remains unexplained on review.
- Confirm that clinical examination, mammographic distortion, ultrasound target and specimen location all refer to the same area rather than assuming they are interchangeable.
- Ask pathology whether the sampled benign fibrosis is an adequate explanation and radiology whether the clip or biopsy track confirms accurate targeting.
- Classify the outcome as discordant when the pathology does not explain the suspicious architecture, then agree repeat vacuum-assisted or surgical sampling in the multidisciplinary team.
- Give the patient the integrated conclusion and next procedure, including why the benign words on one report have not ended the assessment.
- Verify that additional histology is reviewed against the original images and that a final documented concordance decision is assigned.